View Item 

Show simple item record

Sentinel lymph node mapping in gynecologic malignancies
dc.contributor.authorLoar, P.V.
dc.contributor.authorReynolds, R.K.
dc.date.accessioned2017-01-10T19:03:50Z
dc.date.available2017-01-10T19:03:50Z
dc.date.issued2007-10
dc.identifier.citationLoar, P.V.; Reynolds, R.K. (2007). "Sentinel lymph node mapping in gynecologic malignancies." International Journal of Gynecology & Obstetrics 99(1): 69-74.
dc.identifier.issn0020-7292
dc.identifier.issn1879-3479
dc.identifier.urihttps://hdl.handle.net/2027.42/135208
dc.description.abstractLymph node status is the most important prognostic factor for women with vulvar, cervical and endometrial carcinoma and complete lymph node dissection has historically been an integral part of the surgical treatment of these diseases. Lymphadenectomy can be morbid for patients, who may experience wound breakdown, lymphocyst formation or chronic lymphedema, among other problems. Sentinel lymph node mapping is a newer technology that allows selective removal of the first node draining a tumor thereby allowing a potentially less aggressive procedure to be performed. Sentinel node mapping is well accepted for the management of breast carcinoma and cutaneous melanoma, and has resulted in reduced morbidity without adversely affecting survival. Sentinel node mapping is currently being investigated for treatment of gynecologic cancers. Recent studies show promise for incorporating the sentinel node mapping technique for treatment of several gynecologic malignancies.
dc.publisherChurchill Livingstone
dc.publisherWiley Periodicals, Inc.
dc.subject.otherEndometrial carcinoma
dc.subject.otherCervical carcinoma
dc.subject.otherVulvar carcinoma
dc.subject.otherSentinel node
dc.subject.otherGynecologic oncology
dc.titleSentinel lymph node mapping in gynecologic malignancies
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelObstetrics and Gynecology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/135208/1/ijgo69.pdf
dc.identifier.doi10.1016/j.ijgo.2007.06.001
dc.identifier.sourceInternational Journal of Gynecology & Obstetrics
dc.identifier.citedreferenceBats A.S., Clément D., Larousserie F., Lefrère‐Belda M.A., Faraggi M., Froissart M., et al. Sentinel lymph node biopsy improves staging in early cervical cancer. Gynecol Oncol. 105 (1): 2007; 189 – 193
dc.identifier.citedreferenceDe Hullu J.A., Oonk M.H., van der Zee A.G. Modern management of vulvar cancer. Curr Opin Obstet Gynecol. 16 (1): 2004; 65 – 72
dc.identifier.citedreferenceDiSaia P.J., Creasman W.T., Rich W.M. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol. 133 (7): 1979; 825 – 832
dc.identifier.citedreferenceGordinier M.E., Malpica A., Burke T.W., Bodurka D.C., Wolf J.K., Jhingran A., et al. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 90 (3): 2003; 625 – 628
dc.identifier.citedreferenceLevenback C., Burke T.W., Gershenson D.M., Morris M., Malpica A., Ross M.I. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol. 84 (2): 1994; 163 – 167
dc.identifier.citedreferenceLevenback C., Coleman R.L., Burke T.W., Bodurka‐Bevers D., Wolf J.K., Gershenson D.M. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 83 (2): 2001; 276 – 281
dc.identifier.citedreferenceAnsink A.C., Sie‐Go D.M., van der Velden J., Sijmons E.A., de Barros Lopes A., Monaghan J.M., et al. Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study. Cancer. 86 (4): 1999; 652 – 656
dc.identifier.citedreferenceDecesare S.L., Fiorica J.V., Roberts W.S., Reintgen D., Arango H., Hoffman M.S., et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol. 66 (3): 1997; 425 – 428
dc.identifier.citedreferenceBoran N., Kayikcioglu F., Kir M. Sentinel lymph node procedure in early vulvar cancer. Gynecol Oncol. 90 (2): 2003; 492 – 493
dc.identifier.citedreferenceMerisio C., Berretta R., Gualdi M., Pultrone D.C., Anfuso S., Agnese G., et al. Radioguided sentinel lymph node detection in vulvar cancer. Int J Gynecol Cancer. 15 (3): 2005; 493 – 497
dc.identifier.citedreferenceHakam A., Nasir A., Raghuwanshi R., Smith P.V., Crawley S., Kaiser H.E., et al. Value of multilevel sectioning for improved detection of micrometastases in sentinel lymph nodes in invasive squamous cell carcinoma of the vulva. Anticancer Res. 24 (2C): 2004; 1281 – 1286
dc.identifier.citedreferenceRaspagliesi F., Ditto A., Fontanelli R., Maccauro M., Carcangiu M.L., Parazzini F., et al. False‐negative sentinel node in patients with vulvar cancer: a case study. Int J Gynecol Cancer. 13 (3): 2003; 361 – 363
dc.identifier.citedreferenceEcht M.L., Finan M.A., Hoffman M.S., Kline R.C., Roberts W.S., Fiorica J.V. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J. 92 (2): 1999; 204 – 208
dc.identifier.citedreferenceFrumovitz M., Bodurka D.C., Broaddus R.R., Coleman R.L., Sood A.K., Gershenson D.M., et al. Lymphatic mapping and sentinel node biopsy in women with high‐risk endometrial cancer. Gynecol Oncol. 104 (1): 2007; 100 – 103
dc.identifier.citedreferenceMaccauro M., Lucignani G., Aliberti G., Villano C., Castellani M.R., Solima E., et al. Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc‐labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging. 32 (5): 2005; 569 – 574
dc.identifier.citedreferenceNiikura H., Okamura C., Utsunomiya H., Yoshinaga K., Akahira J., Ito K., et al. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol. 92 (2): 2004; 669 – 674
dc.identifier.citedreferencede Hullu J.A., Hollema H., Piers D.A., Verheijen R.H., van Diest P.J., Mourits M.J., et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol. 18 (15): 2000; 2811 – 2816
dc.identifier.citedreferenceDi Stefano A.B., Acquaviva G., Garozzo G., Barbic M., Cvjeticanin B., Meglic L., et al. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2‐year experience. Gynecol Oncol. 99 (3): 2005; 671 – 679
dc.identifier.citedreferenceLouis‐Sylvestre C., Evangelista E., Leonard F., Itti E., Meignan M., Paniel B.J. Sentinel node localization should be interpreted with caution in midline vulvar cancer. Gynecol Oncol. 97 (1): 2005; 151 – 154
dc.identifier.citedreferenceRob L., Robova H., Pluta M., Strnad P., Kacirek J., Skapa P., et al. Further data on sentinel lymph node mapping in vulvar cancer by blue dye and radiocolloid Tc99. Int J Gynecol Cancer. 17 (1): 2007; 147 – 153
dc.identifier.citedreferenceSilva L.B., Silva‐Filho A.L., Traiman P., Triginelli S.A., de Lima C.F., Siqueira C.F., et al. Sentinel node detection in cervical cancer with (99m)Tc‐phytate. Gynecol Oncol. 97 (2): 2005; 588 – 595
dc.identifier.citedreferenceFiorica J., Grendys E., Hoffman M. Intraoperative radiolocalization of the sentinel node in patients with vulvar cancer. Oper Tech Gynecolog Surg. 6: 2001; 27
dc.identifier.citedreferenceMoore D.H., Koh W.J., McGuire W.P., Wilkinson E.J. Vulva. Hoskins W.J., Perez C.A., Young R.C., Barakat R., Markman M., Randall M. Principles and practice of gynecologic oncology. 4th edition. 2005; Lippincott Williams & Wilkins: Philadelphia
dc.identifier.citedreferenceCabanas R.M. An approach for the treatment of penile carcinoma. Cancer. 39 (2): 1977; 456 – 466
dc.identifier.citedreferenceMorton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 127 (4): 1992; 392 – 399
dc.identifier.citedreferenceMorton D.L., Cochran A.J., Thompson J.F., Elashoff R., Essner R., Glass E.C., et al. Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early‐stage melanoma: accuracy and morbidity in MSLT‐I, an international multicenter trial. Ann. Surg. 242 (3): 2005; 302 – 311
dc.identifier.citedreferenceEsSLNer R. Sentinel lymph node biopsy and melanoma biology. Clin Cancer Res. 12 (7 Pt 2): 2006; 2320s – 2325s
dc.identifier.citedreferenceMcMasters K.M., Noyes R.D., Reintgen D.S., Goydos J.S., Beitsch P.D., Davidson B.S., et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol. 86 (4): 2004; 212 – 223
dc.identifier.citedreferenceKim T., Giuliano A.E., Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinoma: a metaanalysis. Cancer. 106 (1): 2006; 4 – 16
dc.identifier.citedreferenceMorrow C.P., Curtin J.P., Townsend D.E. Synopsis of gynecologic oncology. Fourth ed. 1993; Churchill Livingstone: New York
dc.identifier.citedreferenceCreasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., Heller P.B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 60 (8 Suppl): 1987; 2035 – 2041
dc.identifier.citedreferenceOonk M.H.M., Hollema H., DeHullu J.A., van der Zee A.G.J. Prediction of lymph node metastases in vulvar cancer: a review. Int J Gynecol Cancer. 16: 2006; 963 – 971
dc.identifier.citedreferenceMartimbeau P.W., Kjorstad K.E., Kolstad P. Stage IB carcinoma of the cervix, the Norwegian Radium Hospital, 1968–1970: results of treatment and major complications. I. Lymphedema. Am J Obstet Gynecol. 131 (4): 1978; 389 – 394
dc.identifier.citedreferencePodratz K.C., Symmonds R.E., Taylor W.F., Williams T.J. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol. 61 (1): 1983; 63 – 74
dc.identifier.citedreferenceBurrell M.O., Franklin III E.W., Campion M.J., Crozier M.A., Stacy D.W. The modified radical vulvectomy with groin dissection: an eight‐year experience. Am J Obstet Gynecol. 159 (3): 1988; 715 – 722
dc.identifier.citedreferenceMorrow C.P. Surgery for vulvar neoplasia Gynecologic Cancer Surgery. 1996; Churchill Livingstone: New York; 831
dc.identifier.citedreferenceDe Hullu J.A., Hollema H., Lolkema S., Boezen M., Boonstra H., Burger M.P., et al. Vulvar carcinoma. The price of less radical surgery. Cancer. 95 (11): 2002; 2331 – 2338
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ijgo69.pdf
Size:
384.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.